文献速递心胸血管麻醉

体外循环泵流量增加对心脏手术患者肾脏滤过、灌注、氧合及肾小管损伤的影响:一项随机对照试验

Effects of Increased Cardiopulmonary Bypass Pump Flow on Renal Filtration, Perfusion, Oxygenation, and Tubular Injury in Cardiac Surgical Patients: A Randomized Controlled Trial.
PubMed 文献 · Anesthesiology · 2025-07-07

该随机对照试验纳入36例心脏手术患者,比较体外循环期间高流量(2.9 l·min⁻¹·m⁻²,n=19)与标准流量(2.4 l·min⁻¹·m⁻²,n=17)对肾脏的影响。结果显示高流量组肾小球滤过率增加、肾小管损伤标志物释放减少,但肾血流量和氧摄取无差异。

要点

  • 体外循环高流量(2.9 l·min⁻¹·m⁻²)较标准流量(2.4 l·min⁻¹·m⁻²)改善肾小球滤过率。
  • 高流量组尿N-乙酰-β-D-氨基葡萄糖苷酶峰值排泄较低,提示肾小管损伤减轻。
  • 两组肾血流量和肾氧摄取无显著差异,高流量未增加灌注相关不良事件。

核心结论

  • 体外循环期间较标准增加20%的泵流量可改善心脏手术患者肾功能,但未检测到肾血流量或氧供需关系的改变。
  • 较高体外循环流量与较轻的肾小管损伤标志物释放相关。

研究设计与样本

  • 随机、非盲、平行组研究,纳入36例成年心脏手术患者。
  • 高流量组(2.9 l·min⁻¹·m⁻²,n=19)与标准流量组(2.4 l·min⁻¹·m⁻²,n=17)在体外循环期间比较。
  • 肾小球滤过率用碘海醇输注清除率测量,肾血流量用对氨基马尿酸输注清除率校正肾提取率测量。

主要发现

  • 高流量组全身氧输送增加100(95%CI 60至141)ml·min⁻¹·m⁻²,标准流量组增加31(95%CI 1.9至65)ml·min⁻¹·m⁻²,组间P<0.001,Cohen's dz=0.59。
  • 高流量组维持目标平均动脉压所需的去甲肾上腺素剂量较低(0.03[-0.01至0.06]µg·kg⁻¹·min⁻¹ vs. 0.10[0.02至0.19]µg·kg⁻¹·min⁻¹,P=0.048,Cohen's dz=0.62)。
  • 高流量组体外循环期间肾小球滤过率增加6.4(95%CI 1.9至10.9)ml·min⁻¹·1.73m⁻²,标准流量组变化-2.3(95%CI -10.9至6.2)ml·min⁻¹·1.73m⁻²,组间P=0.044,Cohen's dz=0.66。
  • 高流量组和标准流量组尿N-乙酰-β-D-氨基葡萄糖苷酶峰值排泄分别为1.42(0.87至3.6)和3.74(1.5至7.7)单位/µmol肌酐,P=0.049。
  • 两组肾血流量或氧摄取无差异,两组均未见灌注相关不良事件。

临床怎么用

  • 在心脏手术体外循环期间,可考虑将泵流量设置为高于标准流量约20%(如2.9 l·min⁻¹·m⁻²)以改善肾功能并减轻肾小管损伤。
  • 高流量策略可能减少维持目标平均动脉压所需的去甲肾上腺素剂量。

局限性

  • 研究为非盲设计,样本量较小(共36例),可能影响结果解释。
  • 单中心研究,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cardiac surgery with cardiopulmonary bypass (CPB) is associated with impaired renal oxygenation and acute kidney injury. The authors investigated whether an amount higher than their standard blood flow during CPB could improve renal blood flow, the oxygen demand-supply relationship, and function and attenuate tubular injury. METHODS: After ethical approval and informed consent, 36 adult patients undergoing cardiac surgery received either high flow (2.9 l · min -1 · m -2 , n = 19) or standard flow (2.4 l · min -1 · m -2 , n = 17) during CPB in this randomized, nonblinded, parallell-arm study. Systemic hemodynamics and renal variables were measured before and during CPB. Glomerular filtration rate was measured by infusion clearance of iohexol and renal blood flow by infusion clearance of para-aminohippuric acid, corrected for renal extraction of para-aminohippuric acid, using a renal vein catheter. Renal oxygen demand-supply relationship was estimated from renal oxygen extraction and tubular injury assessed by urinary N -acetyl-β- d -glucosaminidase. RESULTS: During CPB, high flow led to a larger increase in systemic oxygen delivery (100 [95% CI, 60 to 141] vs. 31 [1.9 to 65] ml · min -1 · m -2 ]; between-group P < 0.001; effect size Cohen's dz , 0.59) and target mean arterial pressure was maintained at a lower norepinephrine dose (0.03 [-0.01 to 0.06] µg · kg -1 · min -1 ] vs. 0.10 [0.02 to 0.19] µg · kg -1 · min -1 ; P = 0.048; Cohen's dz , 0.62) compared with standard flow. There were no differences in renal blood flow or oxygen extraction between groups. Glomerular filtration rate increased during high-flow CPB (6.4 [1.9 to 10.9] ml · min -1 · 1.73 m -2 ), but not in the standard-flow group (-2.3 [-10.9 to 6.2] ml · min -1 · 1.73 m -2 ; between-group P = 0.044; Cohen's dz , 0.66). The peak urinary excretion of N -acetyl-β- d -glucosaminidase was 1.42 (0.87 to 3.6) versus 3.74 (1.5 to 7.7) units/µmol creatinine in the high-flow and standard-flow groups, respectively ( P = 0.049). No perfusion-related adverse events were seen in either group. CONCLUSIONS: A 20% higher-than-standard CPB flow during cardiac surgery improved renal function, whereas no change in renal blood flow or oxygen demand-supply relationship could be detected. Higher CPB flow was associated with a less pronounced tubular injury marker release compared with standard flow.

来源:Anesthesiology,查看原文。版权归原作者所有。

引用

  1. Wijk J, Cordefeldt-Keiller A, Bragadottir G, et al. Effects of Increased Cardiopulmonary Bypass Pump Flow on Renal Filtration, Perfusion, Oxygenation, and Tubular Injury in Cardiac Surgical Patients: A Randomized Controlled Trial. Anesthesiology. 2025. PMID: 40622858. doi:10.1097/ALN.0000000000005648

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。